Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Cancer Medicine|March 8, 2024
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trialEriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
Ebiomedicine|June 20, 2017
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-Ichi Isa, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitroYasuhiro Koh, Hirotomo Nakata, Kenji Maeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2015
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-ichi Isa, et al.
Cancer Medicine|February 6, 2020
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer studyAkihiro Tamiya, Yasuhiro Koh, Shun-Ichi Isa, et al.
Journal of Medicinal Chemistry|August 18, 2006
Structure-based design of novel HIV-1 protease inhibitors to combat drug resistanceArun K Ghosh, Perali Ramu Sridhar, Sofiya Leshchenko, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancerNorimitsu Kasahara, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
The Oncologist|April 17, 2020
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung CancerHiroaki Akamatsu, Eriko Murakami, Jun Oyanagi, et al.
Journal for Immunotherapy of Cancer|February 15, 2024
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancerRyota Shibaki, Daichi Fujimoto, Tsukasa Nozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2025
Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learningDaichi Fujimoto, Ryota Shibaki, Keiichi Kimura, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Cancer Medicine|March 8, 2024
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trialEriko Murakami, Hiroaki Akamatsu, Shunsuke Teraoka, et al.
Ebiomedicine|June 20, 2017
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-Ichi Isa, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitroYasuhiro Koh, Hirotomo Nakata, Kenji Maeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2015
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCRMasaru Watanabe, Tomoya Kawaguchi, Shun-ichi Isa, et al.
Cancer Medicine|February 6, 2020
Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer studyAkihiro Tamiya, Yasuhiro Koh, Shun-Ichi Isa, et al.
Journal of Medicinal Chemistry|August 18, 2006
Structure-based design of novel HIV-1 protease inhibitors to combat drug resistanceArun K Ghosh, Perali Ramu Sridhar, Sofiya Leshchenko, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancerNorimitsu Kasahara, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
The Oncologist|April 17, 2020
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung CancerHiroaki Akamatsu, Eriko Murakami, Jun Oyanagi, et al.
Journal for Immunotherapy of Cancer|February 15, 2024
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancerRyota Shibaki, Daichi Fujimoto, Tsukasa Nozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2025
Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learningDaichi Fujimoto, Ryota Shibaki, Keiichi Kimura, et al.
Pageof 15